Advanced Practice Providers Oncology Summit.
Oncology 102 Virtual Conference
October 24th - 26th 2024
A Hematology and Oncology Primer for Advanced Practice Providers
To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership
with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for
Advanced Practice Providers.” In this two-and-a-half-day virtual program, clinicians will gain a
greater understanding of cancer treatment, cancer therapies, side effects, supportive care
strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment
strategies for hematologic disorders and solid malignancies. Participation in the program will
allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide
APPs with a deeper understanding of the cancer treatment strategies they need to support and
care for cancer patients as part of the multidisciplinary oncology care team.
This program is appropriate for nurse practitioners, physician assistants, nurses, and
pharmacists in hematology/oncology seeking an in-depth review of cancer treatment strategies
and therapies.
*Students - Fellows
Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.
If you would like to attend as a Student, please contact info@horizoncme.com for further information.
**Industry Employee - $300+
**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc).
Commercial Support: Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (Virtual Conference) Fall 2024 is supported in part by independent medical educational grants from Merck Sharp & Dohme Corp.
Agenda
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
ALL TIMES LISTED ARE FOR THE EASTERN STANDARD TIME ZONE
Thursday, October 24, 2024 | |
11:00am | Welcome, Introductions, & CE Housekeeping |
11:15am | (01) Biomarker Testing: Understanding The How, Benefits, and Translating to Patient Care » Anthony J. Olszanski, RPh, MD – Vice-Chair, Department of Hematology/Oncology Director, Phase 1 Developmental Therapeutics Program Director, Medical Oncology Melanoma Program Fox Chase Cancer Center |
11:45am | (02) Patience and Understanding: Palliative Care for the APP » Alicia M. Rigby, MSN, RN, APRN, AOCNP – Nurse Practitioner University of California, Davis |
12:45pm | Stump the Faculty – Panel Q&A Discussion |
1:00pm | Meet-the-Clinician Break |
1:15pm | (03) Pain Management: An Integral Component of Caring for the Oncology Patient » Tanya Uritsky, PharmD, BCPP – Opioid Stewardship Coordinator University of Pennsylvania |
2:15pm | (04) What is Chemotherapy » Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP – Clinical Oncology Pharmacist University of Illinois College of Pharmacy |
3:15pm | Stump the Faculty – Panel Q&A Discussion |
3:30pm | Meet-the-Clinician Break |
3:45pm | (05) Treating Melanoma in 2024: The Age of Immunotherapy and Targeted Therapy » Suzanne McGettigan, CRNP – Nurse Practitioner Perelman Center for Advanced Medicine, Abramson Cancer Center |
4:15pm | (06) Identification and Management of Immune Related Adverse Events » Marianne Davies, DNP, ACNP, AOCNP, FAAN – Associate Professor Yale University Yale School of Nursing Oncology Nurse Practitioner-Thoracic & Solid Tumor Senior Advanced Practice Provider II Smilow Cancer Hospital at Yale-New Haven Yale Comprehensive Cancer Center |
4:45pm | (07) Deciphering Radiation Oncology: A Deeper Dive into Acute and Late Effects from Treatment » Bridgett Harr, CNP – Nurse Practitioner Cleveland Clinic |
5:45pm | Stump the Faculty – Panel Q&A Discussion |
6:00pm | Adjourn |
Friday, October 25, 2024 | |
7:55am | Welcome, Introductions, & CE Housekeeping |
8:00am | (08) Neuro-Oncology for the APP: What is Going on Up There? » Vanessa Nevins, PA-C, RDMS, RT – Oncology Physician Assistant, Yale New Haven Smilow Cancer Hospital |
8:30am | Stump the Faculty – Panel Q&A Discussion |
8:45am | Meet-the-Clinician Break |
9:00am | (09) Breast Oncology: Awareness and Current Knowledge » Kayla Freeman, DNP, APRN, FNP-C – Breast Oncology Nurse Practitiner, Emory Winship Cancer Institute |
10:00am | (10) Gynecologic Malignancies: Clinical Pearls » Rachel Frankenthal, PA-C – Gynecologic Oncologic Physician Associate UCLA Health |
10:30am | Stump the Faculty – Panel Q&A Discussion |
10:45am | (11) Lung Cancer: Updates and Advancements » Beth Sandy, MSN, CRNP – Nurse Practitioner, Thoracic Medical Oncology Abramson Cancer Center, University of Pennsylvania |
11:45am | Lunch Break |
12:15pm | (12) Updates in Treating and Managing Patients with Prostate, Bladder and Renal Cell Carcinoma » Brenda Martone, MSN, ANP-BC, AOCNP – Adult Nurse Practitioner Northwestern Medicine » Laura S. Wood, RN, MSN, OCN – Cleveland Clinic |
1:30pm | Stump the Faculty – Panel Q&A Discussion |
1:45pm | Meet-the-Clinician Break |
2:00pm | (13) Head and Neck Cancer: Diagnosis, Staging, and Management » Kristin M. Daly, MSN, ANP-BC, AOCNP – Medical Oncology Siteman Cancer Center Washington University, St. Louis School of Medicine |
3:00pm | (14) Colorectal: Current and Emerging Therapies » Jessica Guadagno, PA – Oncology Physician Assistant Winship Cancer Institute, Emory University |
4:00pm | Break |
4:10pm | (15) Hepatic and Pancreatic » TBA |
5:10pm | (16) Gastric » Jessica Guadagno, PA – Oncology Physician Assistant Winship Cancer Institute, Emory University |
5:40pm | Stump the Faculty – Panel Q&A Discussion |
5:55pm | Adjourn |
Saturday, October 26, 2024 | |
7:55am | Welcome, Introductions, & CE Housekeeping |
8:00am | (17) A Deep Dive into Multiple Myeloma » Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN – Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic » Donna Catamero, ANP-BC, OCN, CCRC – Associate Director of Myeloma Research Icahn School of Medicine at Mount Sinai Hospital New York, NY |
9:00am | Stump the Faculty – Panel Q&A Discussion |
9:15am | (18) Advances in CLL for the Clinical Oncology APP » Lisa Nodzon PhD, APRN, AOCNP – Advanced Registered Nurse Practitioner Moffitt Cancer Center |
9:45am | (19) Follicular Lymphoma for the Clinical Oncology APP » Amy Goodrich, RN, MSN, CRNP – Nurse Practitioner Johns Hopkins |
10:15am | Stump the Faculty – Panel Q&A Discussion |
10:30am | Meet-the-Clinician Break |
10:50am | (20) Understanding and Managing Acute Leukemia, Myelodysplastic Syndrome, and Myelofibrosis » Jennie M. Goble, PA-C – Physician Assistant Mayo Clinic |
11:50am | Lunch Break |
12:20pm | (21)Benign Heme » Peter Hakos, PA-C – Cleveland Clinic » Lauren Imboden, PA-C – Atrium Health Wake Forest Baptist |
1:20pm | (22) An Update of Current Treatment Options for Patients with Diffuse Large B-Cell Lymphoma » Amit Mehta, MD – Oncologist, Hematologist The Kirklin Clinic of UAB Hospital |
2:20pm | (23) Sexuality » Anne Katz, PhD, RN, FAAN – AASECT-Certified Sexuality Counselor CancerCare Manitoba |
3:20pm | Stump the Faculty – Panel Q&A Discussion |
3:35pm | Adjourn |
Available Credit
- 15.25 AMA PRA Category 1 Credit™Horizon CME designates this Live activity for a maximum of 15.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 15.25 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 15.25 credit.
- 2.25 PharmacologyThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 2.25 credit.
Learning Objectives
Learning Objectives
- Outline strategies for the treatment of common solid and hematologic malignancies
- Summarize the role of genetics and molecular testing in cancer care
- Implement palliative care and pain management strategies for patients with cancer
- Discuss strategies for the administration and management of chemotherapy
- Identify and appropriately manage immune-related adverse events
- Recognize and treat the adverse effects associated with radiation oncology
Intended Learners
This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.
COVID-19 & Health Safety
Conference is virtual. Attend fully online.